Drug Shortage Report for METHOTREXATE INJECTION, BP
Report ID | 246222 |
Drug Identification Number | 02422166 |
Brand name | METHOTREXATE INJECTION, BP |
Common or Proper name | METHOTREXATE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 7.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL |
Packaging size | 0.3mL |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-12-19 |
Estimated end date | 2025-01-30 |
Actual end date | 2025-02-04 |
Shortage status | Resolved |
Updated date | 2025-02-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2025-02-05 | French | Compare |
v3 | 2025-02-05 | English | Compare |
v2 | 2024-12-20 | French | Compare |
v1 | 2024-12-20 | English | Compare |
Showing 1 to 4 of 4